FEYCX
Price
$26.98
Change
-$0.31 (-1.14%)
Updated
Jun 13 closing price
Net Assets
4.66B
JFTUX
Price
$27.26
Change
-$0.29 (-1.05%)
Updated
Jun 13 closing price
Net Assets
5.88B
Interact to see
Advertisement

FEYCX vs JFTUX

Header iconFEYCX vs JFTUX Comparison
Open Charts FEYCX vs JFTUXBanner chart's image
Fidelity Advisor Asset Manager 85% C
Price$26.98
Change-$0.31 (-1.14%)
VolumeN/A
Net Assets4.66B
JPMorgan Investor Growth R6
Price$27.26
Change-$0.29 (-1.05%)
VolumeN/A
Net Assets5.88B
FEYCX vs JFTUX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FEYCX vs. JFTUX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEYCX is a Buy and JFTUX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFTUX has more cash in the bank: 5.88B vs. FEYCX (4.66B). JFTUX pays higher dividends than FEYCX: JFTUX (2.61) vs FEYCX (0.40). FEYCX was incepted earlier than JFTUX: FEYCX (19 years) vs JFTUX (8 years). FEYCX (1.69) is less costly to investors than JFTUX (0.49). FEYCX is a more actively managed with annual turnover of: 16.00 vs. JFTUX (5.00). FEYCX has a lower initial minimum investment than JFTUX: FEYCX (0) vs JFTUX (15000000). JFTUX annual gain was more profitable for investors over the last year : 8.70 vs. FEYCX (6.95). JFTUX return over 5 years is better than : 51.66 vs. FEYCX (47.36).
FEYCXJFTUXFEYCX / JFTUX
Total Expense Ratio1.690.49345%
Annual Report Gross Expense Ratio1.690.49345%
Fund Existence19 years8 years-
Gain YTD5.1854.621112%
Front LoadN/AN/A-
Min. Initial Investment015000000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.66B5.88B79%
Annual Yield % from dividends0.402.6115%
Returns for 1 year6.958.7080%
Returns for 3 years34.4734.9199%
Returns for 5 years47.3651.6692%
Returns for 10 years62.56N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MASS7.310.12
+1.67%
908 Devices
RCUS9.24-0.11
-1.18%
Arcus Biosciences
TXMD1.17-0.03
-2.50%
TherapeuticsMD
ONC269.63-6.90
-2.50%
BeOne Medicines Ltd
DFH22.76-0.79
-3.35%
Dream Finders Homes